Key result
Mice over-expressing both creatine transporter and creatine kinase in the heart exhibited a 51% higher PCr/ATP ratio compared to single transgenic mice.
Why the study?
High heart rate and diminutive size pose challenges for in vivo mouse 31P-CMRS, and whether combined elevation of myocardial creatine and creatine kinase synergistically augments energetic status was unknown.
Does double transgenic expression of Creatine Transporter and Creatine Kinase increase the PCr/ATP ratio in the mouse heart compared to single transgenic expression?
Does double transgenic expression of Creatine Transporter and Creatine Kinase increase the PCr/ATP ratio in the mouse heart compared to single transgenic expression?
A refined high-resolution 31P-CMRS technique demonstrated that mice over-expressing both creatine and CK in the heart exhibit a synergistic elevation in PCr/ATP, suggesting therapeutic potential for chronic heart failure.
Answers are grounded in this paper and cite their sources.
Does not inform clinical practice; leaves open whether dual overexpression could enhance energetics in human heart failure.
Phosphorus cardiovascular magnetic resonance spectroscopy (31P-CMRS) has emerged as an important tool for the preclinical assessment of myocardial energetics in vivo. However, the high rate and diminutive size of the mouse heart is a challenge, resulting in low resolution and poor signal-to-noise. Here we describe a refined high-resolution 31P-CMRS technique and apply it to a novel double transgenic mouse (dTg) with elevated myocardial creatine and creatine kinase (CK) activity. We hypothesised a synergistic effect to augment energetic status, evidenced by an increase in the ratio of phosphocreatine-to-adenosine-triphosphate (PCr/ATP). Single transgenic Creatine Transporter overexpressing (CrT-OE, n = 7) and dTg mice (CrT-OE and CK, n = 6) mice were anaesthetised with isoflurane to acquire 31P-CMRS measurements of the left ventricle (LV) utilising a two-dimensional (2D), threefold under-sampled density-weighted chemical shift imaging (2D-CSI) sequence, which provided high-resolution data with nominal voxel size of 8.5 µl within 70 min. (1H-) cine-CMR data for cardiac function assessment were obtained in the same imaging session. Under a separate examination, mice received invasive haemodynamic assessment, after which tissue was collected for biochemical analysis. Myocardial creatine levels were elevated in all mouse hearts, but only dTg exhibited significantly elevated CK activity, resulting in a 51% higher PCr/ATP ratio in heart (3.01 ± 0.96 vs. 2.04 ± 0.57—mean ± SD; dTg vs. CrT-OE), that was absent from adjacent skeletal muscle. No significant differences were observed for any parameters of LV structure and function, confirming that augmentation of CK activity does not have unforeseen consequences for the heart. We have developed an improved 31P-CMRS methodology for the in vivo assessment of energetics in the murine heart which enabled high-resolution imaging within acceptable scan times. Mice over-expressing both creatine and CK in the heart exhibited a synergistic elevation in PCr/ATP that can now be tested for therapeutic potential in models of chronic heart failure.
No takes yet. Share an insight, caveat, or question.
Maguire et al. (2023) studied Myocardial energetics (n=13). Double transgenic (dTg) overexpression of creatine transporter and creatine kinase vs. Single transgenic Creatine Transporter overexpressing (CrT-OE) mice was evaluated on Myocardial PCr/ATP ratio (51% higher). Mice over-expressing both creatine transporter and creatine kinase in the heart exhibited a 51% higher PCr/ATP ratio compared to single transgenic mice.
Synapse has enriched 10 related papers. Consider them for comparative context: